AzTrials
AzTrials

Colorectal CancerNCT03078361

Latinos CARES (Colorectal Cancer Awareness, Research, Education and Screening)

A study testing Immunochemical Fecal Occult Blood Test (I-FOBT) Kit, LATINOS CARES Toolkit and Standard Intervention in people with Colorectal Cancer and Colorectal Carcinoma, run by H. Lee Moffitt Cancer Center and Research Institute at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to conduct 4 focus groups and recruit for 12 participants per focus group to explore community members' views about colorectal cancer screening (CRCS) processes and perceived benefits and impediments, what information they believe should be communicated, communication preferences (style… Read more about this study

Who is it for?
Ages 50 to 70 yearsHealthy volunteers can take part
Conditions the study is for
Colorectal Cancer, Colorectal Carcinoma
What is being tested?
Immunochemical Fecal Occult Blood Test (I-FOBT) Kit, LATINOS CARES Toolkit and Standard Intervention
Could I receive a placebo?
No, everyone receives an active treatment
How many people
159 participants
Where
1 siteUnited States
Study dates
28 Apr 2014to 26 Oct 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 50 to 70 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Men and women, age 50-75 years
  • Self-identify as Hispanic/Latino
  • Able to understand, read, and speak Spanish
  • Prefer to receive health information in Spanish
  • Previously screened or not screened

Who cannot join

None listed.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • H. Lee Moffitt Cancer Center and Research Institute

    Tampa, Florida, 33612

Other trials in United States

About this study

Official title: Latinos CARES (Colorectal Cancer Awareness, Research, Education and Screening) Project

The purpose of this study is to conduct 4 focus groups and recruit for 12 participants per focus group to explore community members' views about colorectal cancer screening (CRCS) processes and perceived benefits and impediments, what information they believe should be communicated, communication preferences (style, tone) and perceptions of screenings.

Being tested
Immunochemical Fecal Occult Blood Test (I-FOBT) Kit, LATINOS CARES Toolkit, Standard Intervention
Keywords
cancer screening, colon
Medical subject headings
Colorectal Neoplasms

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Immunochemical Fecal Occult Blood Test (I-FOBT) KitOther

    Both intervention groups will receive an I-FOBT kit (by study coordinator) with verbal and written instructions in Spanish on how to complete the stool sampling at home within 1 week, and mail the completed kit in the pre-addressed, postage paid mailer. Patients with abnormal results will receive a call explaining the meaning of an abnormal I-FOBT and encouraging them to take specific next steps.

  • LATINOS CARES ToolkitBehavioural

    DVD + photonovella booklet), about colorectal cancer screening (CRCS) targeted for a Latino medically underserved population.

  • Standard InterventionBehavioural

    Standard intervention (CDC brochure) on colorectal cancer screening in community health clinics.

Study groups in NCT03078361
Study groupRoleWhat they receive
LATINOS CARES ToolkitActive comparatorParticipants assigned to the LATINOS CARES condition will receive an I-FOBT kit, DVD and photonovella booklet from the study coordinator. The participant will view the DVD in a private area (headphones are available) using a portable DVD player in clinic before seeing the provider. The DVD will be about 8-10 minutes long. The participant will take the LATINOS CARES toolkit and I-FOBT home after the clinic visit. The participant will be instructed to re-review the materials and complete the I-FOBT stool sampling at home.
Receives: Other: Immunochemical Fecal Occult Blood Test (I-FOBT) Kit; Behavioral: LATINOS CARES Toolkit
Standard Intervention (SI)Active comparatorParticipants assigned to the standard brochure (SI) will be provided a packet containing the CDC Spanish-language tri-fold brochure titled Screen for Life and an I-FOBT card. The participant will be instructed to review the materials in clinic and complete the I-FOBT stool sampling at home. This brochure describes CRC, risk factors, symptoms, screening tests, benefits of screening, and insurance coverage.
Receives: Other: Immunochemical Fecal Occult Blood Test (I-FOBT) Kit; Behavioral: Standard Intervention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Rate of Feedback from Community Advisory Board

    Successful collection of feedback to complete production of Spanish-language LATINOS CARES Intervention.

    This aim involves no statistical analysis except the summary statistics for the participants. To adapt (transcreate) and produce an educational intervention entitled LATINOS CARES (DVD + photonovella booklet), about colorectal cancer screening (CRCS) targeted for a Latino medically underserved population. BENCHMARK: Production of Spanish-language LATINOS CARES intervention that is easy-to understand, salient, and culturally suitable.

    Measured: Up to 4 months

Secondary outcomes (2)
  1. Rate of Receipt of I-FOBT from Participants

    BENCHMARK: Receipt of Immunochemical Fecal Occult Blood Test (I-FOBT home kit).

    Measured: Up to 4 months

  2. Rate of Receipt of Assessments from Participants

    BENCHMARK: Receipt of Assessments.

    Measured: Up to 4 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Mar 2017
  2. Study start28 Apr 2014
  3. Primary completion14 Jul 2016
  4. Study completion26 Oct 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Screening
Allocation
Randomised
Intervention model
Parallel groups
Model description
After completion of baseline assessments, participants will be randomized so that the study personnel are unaware of the intervention assignment at the time of the baseline assessment.
Masking
None (open label)
Enrolment
159 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03078361
Sponsor's protocol ID
MCC-17665
Status last verified
Aug 2022
First submitted
3 Mar 2017
Last updated
11 Jan 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Chavarria EA, Christy SM, Feng H, Miao H, Abdulla R, Gutierrez L, Lopez D, Sanchez J, Gwede CK, Meade CD. Online Health Information Seeking and eHealth Literacy Among Spanish Language-Dominant Latino Adults Receiving Care in a Community Clinic: Secondary Analysis of Pilot Randomized Controlled Trial Data. JMIR Form Res. 2022 Oct 13;6(10):e37687. doi: 10.2196/37687.

    PubMed 35238785
  • Christy SM, Cousin LA, Sutton SK, Chavarria EA, Abdulla R, Gutierrez L, Sanchez J, Lopez D, Gwede CK, Meade CD. Characterizing Health Literacy Among Spanish Language-Preferring Latinos Ages 50-75. Nurs Res. 2021 Set/Oct 01;70(5):344-353. doi: 10.1097/NNR.0000000000000519.

    PubMed 33990120

Questions about this trial

What is this clinical trial studying?

A study testing Immunochemical Fecal Occult Blood Test (I-FOBT) Kit, LATINOS CARES Toolkit and Standard Intervention in people with Colorectal Cancer and Colorectal Carcinoma, run by H. Lee Moffitt Cancer Center and Research Institute at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 11 Jan 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Rate of Feedback from Community Advisory Board (time frame: Up to 4 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03078361, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Jan 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in